Instrument Inactif

Communiqués Prosensa Holding NV

Actions

NL0010524443

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

2014	Nouvelle avance du Nyse qui compte sur les banques centrales	RE
2014	NASDAQ COMPOSITE : Wall Street clôture en hausse	RE

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Prosensa Announces Intent to Voluntarily Delist From NASDAQ	30/01/15	GL
Prosensa Announces Shareholder Approval of Certain Matters Relating to the BioMarin Tender Offer	13/01/15	GL
Prosensa NV : BioMarin and Prosensa Announce Expiration of the Hart-Scott-Rodino Waiting Period for BioMarin's Proposed Acquisition of Prosensa	27/12/14	PU
Prosensa NV : Cure Duchenne and Prosensa to Present Collaboration at Partnering for Cures Conference	12/11/14	BU
Prosensa NV : start indiening registratiedossier bij FDA voor Duchenne-medicijn drisapersen	13/10/14	PU
Prosensa extends the re-dosing of drisapersen in Europe in patients with Duchenne muscular dystrophy	26/09/14	GL
Prosensa NV : -resultaten tweede kwartaal 2014 en recente ontwikkelingen	13/08/14	PU
Prosensa NV : to Present at the Wedbush 2014 Life Sciences Conference	06/08/14	PU
Prosensa NV : versterkt Management Team en Raad van Commissarissen	30/06/14	PU
Prosensa Awarded $200,000 Research Grant from PPMD	27/06/14	GL
Prosensa NV : voltooit rekrutering patiënten in natuurlijke beloopstudie	27/06/14	PU
Prosensa NV : kondigt registratieroute aan voor drisapersen als mogelijk medicijn tegen spierziekte Duchenne	06/06/14	PU
Prosensa to Present at the Jefferies 2014 Global Healthcare Conference	28/05/14	GL
Prosensa NV : jaarresultaten 2013 en recente ontwikkelingen	18/03/14	PU
Prosensa Reports Initial Findings from the Further Clinical Data Analyses of Drisapersen for the Treatment of Duchenne Muscular Dystrophy	16/01/14	GL
Prosensa Holding NV : Prosensa Comments on Drisapersen Program Update	19/12/13	PU
Prosensa Holding NV : Prosensa Announces Extraordinary Shareholders Meeting to Appoint Dr. Georges Gemayel	10/12/13	PU
Prosensa Holding NV : Prosensa and Partners Awarded Second European Consortium FP7 Research Grant	25/11/13	PU
Prosensa Holding NV : Prosensa Announces Third Quarter 2013 Financial Results and Recent Corporate Developments	18/11/13	PU
Prosensa Holding Nv : Prosensa Announces Third Quarter 2013 Financial Results and Recent Corporate Developments	18/11/13	AT

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Prosensa Holding NV

Actions

NL0010524443

Communiqués

Filtres